News

CHS/Pfizer Care until Cure Research Program

  • October 20, 2015
  • News

This program allows Canadian investigators to conduct research on medical and psychosocial aspects of bleeding disorders, including outcome evaluation. Grants are awarded for clinical research in fields relevant to improving the quality of life for persons with hemophilia, persons with von Willebrand disease or other inherited bleeding disorders, persons with related conditions such as HIV or hepatitis C, and carriers of an inherited bleeding disorder. Individual grants valued at $75,000 per year will be awarded to researchers for a maximum of $150,000, which can be expended over 2 or 3 years. If a two-year award is provided, the second year of funding is dependent on evidence of progress as described in the required progress report. Grant funding will begin on April 1, 2016.

http://www.hemophilia.ca/en/research/the-chs—pfizer-care-until-cure-research-program/

Application Deadline: November 13, 2015